Compounds > fluorescein
Page last updated: 2024-08-22

fluorescein and Retrolental Fibroplasia

fluorescein has been researched along with Retrolental Fibroplasia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chen, KJ; Chou, HD; Hwang, YS; Lai, CC; Ling, XC; Liu, L; Wang, NK; Wu, WC1
Chen, Y; Lao, J; Li, H; Mao, J; Shao, Y; Shen, L; Yu, X; Zhang, C1
Fung, TH; Mordant, DJ; Muqit, MM; Patel, CK; Smith, LM1
Hersetyati, R; Kusaka, S; Lam, GC; McMenamin, PG; Tahija, SG1
Azuma, N; Hiraoka, M; Kobayashi, Y; Nishina, S; Yokoi, T1
Bullard, LE; Penn, JS; Tolman, BL1

Other Studies

6 other study(ies) available for fluorescein and Retrolental Fibroplasia

ArticleYear
COMPARISON BETWEEN ORAL AND INTRAVENOUS ULTRAWIDE-FIELD FLUORESCEIN ANGIOGRAPHY IN THE CLINICAL FOLLOW-UP OF CHILDREN WITH A HISTORY OF RETINOPATHY OF PREMATURITY OR PREMATURITY.
    Retina (Philadelphia, Pa.), 2022, 07-01, Volume: 42, Issue:7

    Topics: Adolescent; Child; Fluorescein; Fluorescein Angiography; Follow-Up Studies; Humans; Infant, Newborn; Retinal Vessels; Retinopathy of Prematurity

2022
ULTRA-WIDE-FIELD IMAGING AND INTRAVENOUS FUNDUS FLUORESCEIN ANGIOGRAPHY IN INFANTS WITH RETINOPATHY OF PREMATURITY.
    Retina (Philadelphia, Pa.), 2020, Volume: 40, Issue:12

    Topics: Birth Weight; Diagnostic Imaging; Feasibility Studies; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Injections, Intravenous; Male; Ophthalmoscopy; Retinopathy of Prematurity

2020
Noncontact high-resolution ultra-wide-field oral fluorescein angiography in premature infants with retinopathy of prematurity.
    JAMA ophthalmology, 2014, Volume: 132, Issue:1

    Topics: Administration, Oral; Cyclopentolate; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Male; Mydriatics; Pupil; Retinal Vessels; Retinopathy of Prematurity

2014
Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity.
    The British journal of ophthalmology, 2014, Volume: 98, Issue:4

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Capillary Permeability; Female; Fluorescein; Fluorescein Angiography; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Intravitreal Injections; Male; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; Retrospective Studies; Vascular Endothelial Growth Factor A

2014
Fluorescein staining of the vitreous during vitrectomy for retinopathy of prematurity.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:8

    Topics: Birth Weight; Fluorescein; Fluorescein Angiography; Gestational Age; Humans; Infant; Infant, Newborn; Injections, Intravenous; Intravitreal Injections; Retinal Detachment; Retinopathy of Prematurity; Staining and Labeling; Triamcinolone Acetonide; Vitrectomy; Vitreous Body

2011
Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity.
    Free radical biology & medicine, 1997, Volume: 22, Issue:6

    Topics: Animals; Animals, Newborn; Antioxidants; Capillaries; Chromans; Dextrans; Disease Models, Animal; Fluorescein; Fluorescein-5-isothiocyanate; Fluoresceins; Humans; Infant, Newborn; Injections, Intraperitoneal; Ink; Oxygen; Rats; Rats, Sprague-Dawley; Retina; Retinopathy of Prematurity

1997